Abstract

The coronavirus (COVID-19, SARS-Co-2) heavily swept the globe for several years. However, the healthcare state and legislature for COVID-19 is generally different due to various socioeconomic conditions of different countries. The more powerful vaccines, drugs or therapeutic strategy should be gradually superseded for current ones. The origin and hidden nature of COVID-19 pandemics and medication should be elucidated. The global vaccinations and therapeutic evaluation are ongoing now. Advanced knowledge and opinion continues to grow. The existing knowledge and technology for COVID-19 should be revaluated. The epidemic condition, different types of viral character, human vaccination, and therapeutic variability worldwide totally determine the outcomes and capability against COVID-19. Different strategic platforms can reach different therapeutic responses and benefit. To reduce viral-induced social damage, a possibility of futuristic guidelines in different medications should be established in the upcoming decade. This article summarizes this spectrum of diagnostic and therapeutic achievements into COVID-19 trials.

Keywords

covid-19, viral pathology, herbal medicine, drug development, viral prevention, viral transmission